Unlike other pathologies, amyotrophic lateral sclerosis (ALS) cannot be reproduced accurately in animal models, complicating ...

The 2014 social media trend put the spotlight on unanswered questions and needed treatments for ALS. Will its return help? We ...

The results of the MIROCALS randomized clinical trial have shown that adding low-dose interleukin-2 (IL2LD) to standard ...

"I feel like if I did sit in a recliner and played the whole 'woe is me' card, I would be a lot worse off," musician John ...

Apple is planning to allow users to natively control iPhones, iPads, and other devices using brain signals later this year, ...

Two B.C. athletes will take part in 18 triathlons all across Canada as part of a fundraising journey for ALS research.

MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS) ...

She was a writer and a top editor at publications as diverse as The Nation, Vogue and Entertainment Weekly. She also helped ...

Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose ...

The iPhone-maker is working with startup Synchron on new brain-computer interfaces to assist people with disabilities.

NeuroSense expands PrimeC production, partners with a contract organization, and targets early Canadian entry amid a $100–150 ...